Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Late-Breaking Abstracts Session: New treatments and targets for airway disease

Oral Presentation
Chairs: I. M. Adcock (London, United Kingdom), G. Caramori (Ferrara, Italy)

Download all media

Late-breaking abstract: Inhaled pan-selectin antagonist bimosiamose in COPD: A double-blind, randomized, placebo-controlled phase II study H. Watz, D. Bock, M. Meyer, K. Schierhorn, K. Vollhardt, C. Woischwill, F. Pedersen, A. Kirsten, K. M. Beeh, W. Meyer-Sabellek, H. Magnussen, J. Beier (Grosshansdorf, Henningsdorf, Wiesbaden, Germany)
Late-breaking abstract: Local and systemic distribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure A. Turowska, N. Baumgartl, J. Kuhlmann, H. Garn (Marburg, Germany)
Late-breaking abstract: Pre-clinical characterization of RP3128, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders K. Routhu, M. Muthuppalaniappan, G. Merikapudi, K. Varanasi, S. Veeraraghavan, S. Viswanadha, S. Vakkalanka (Hyderabad, India)
Late-breaking abstract: Pre-clinical efficacy of RP5090 in PI3Kδ mediated airway disorders K. Routhu, K. Varanasi, S. Veeraraghavan, M. Muthuppalaniappan, G. Babu, S. Viswanadha, S. Vakkalanka (Hyderabad, India)
Late-breaking abstract: The effects of roxithromycin as anti-inflammatoy agent on clinical outcomes in patient with bronchiectasis: A double blinded randomized controlled study S. Juthong, S. Eiamsa-ard (HatYai, Thailand)
Late-breaking abstract: Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: The GLOW3 trial K. M. Beeh, A. Drollman, L. Di Scala, R. Smith (Wiesbaden, Germany; Basel, Switzerland; Horsham, United Kingdom)
Late-breaking abstract: Preclinical evaluation of an inhibitor of cytosolic phospholipase A₂α for the treatment of asthma C. Hewson, S. Patel, L. Calzetta, H. Campwala, S. Havard, E. Luscombe, P. Clarke, P. Peachell, M. Matera, M. Cazzola, C. Page, W. Abraham, C. Williams, J. Clark, N. Clarke, M. Yeadon (Sandwich, Sheffield, London, United Kingdom; Rome, Naples, Italy; Miami Beach, Cambridge, United States Of America)
Late-breaking abstract: Inhaled calcium salts reduce tobacco smoke induced airway inflammation and improve lung pathology J. Kenyon, P. Woodman, D. Spicer, P. Wright, V. Russell, R. Clarke, D. Hava (Lexington, United States Of America; Slough, United Kingdom)